Viewbix Inc. Receives Stockholder Approval for Acquisition of Quantum X Labs– A Hub for Quantum Algorithms, Navigation and Atomic Clocks
Viewbix (Nasdaq: VBIX) received majority stockholder written consent to proceed with its previously announced acquisition of Quantum X Labs, entered under a definitive share purchase agreement dated Dec 15, 2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Viewbix (Nasdaq: VBIX) received majority stockholder written consent to proceed with its previously announced acquisition of Quantum X Labs, entered under a definitive share purchase agreement dated Dec 15, 2025. The deal contemplates Viewbix acquiring 85%–100% of Quantum on a fully diluted basis and transfers Quantum's IP portfolio, including quantum algorithms, navigation/GPS alternatives, atomic clocks, and quantum error correction technology.
At closing Viewbix will issue common stock and pre-funded warrants equal to approximately 40% of its capital stock as of the Agreement Date (including 800,000 shares in a related private placement) with up to 12,702,847 additional shares or pre-funded warrants payable upon milestone achievement. Closing remains subject to due diligence and regulatory approvals; the company expects the transaction to close in the coming weeks and will file a Schedule 14C information statement.
Positive
- Acquisition targets 85%–100% of Quantum share capital
- Transfers IP in quantum algorithms, navigation, atomic clocks, and error correction
- Consideration included 800,000 related private placement shares
- Potential earnout up to 12,702,847 additional shares/warrants
Negative
- Issuance represents approximately 40% of Viewbix capital stock as of Dec 15, 2025
- Transaction remains subject to final due diligence and regulatory approvals
- Effective stockholder actions delayed until 20 days after Schedule 14C is furnished
Details
News Market Reaction – VBIX
On Jan 5, the day this news came out, VBIX closed 4.27% above the previous close.
Data tracked by StockTitan Argus for the Jan 5 session.
Key Figures
- Ownership to Acquire
- 85%–100%
- Quantum X Labs issued and outstanding share capital
- Initial Equity Issuance
- 40%
- VBIX capital stock as of Dec 15, 2025 at closing
- Private Placement Shares
- 800,000 shares
- Common stock in related private placement at closing
- Milestone Consideration
- 12,702,847 shares
- Potential additional common stock or pre-funded warrants on milestones
- Effectiveness Delay
- 20 days
- Effective date after definitive Schedule 14C mailing
- Price Move
- 7.19%
- VBIX 24h price change prior to this article
- 52-week Range
- $0.9605–$12.00
- VBIX 52-week low and high before this news
- Market Cap
- $16,325,700
- VBIX market capitalization prior to the news
Historical Context
-
Spotlighted Quantum X Labs hub and reiterated acquisition timeline and scope.
-
Provisional patent for quantum‑enhanced clinical trials plus deal timing reminder.
-
Definitive share purchase agreement to acquire 85%–100% of Quantum X Labs.
-
Updated term sheet reducing initial equity issuance to 40% with earn‑outs.
-
Sale of Cortex Media and disclosure of non‑binding term sheet for Quantum.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
pre-funded warrants financial
quantum algorithms technical
atomic clocks technical
quantum error correction technical
stockholder approval regulatory
schedule 14c regulatory
AI-generated analysis. How Rhea-AI works. Not financial advice.
The acquisition, which is subject to closing conditions, would encompass Quantum’s proprietary intellectual property portfolio, including an innovative patent for AI-Quantum Error Correction
Tel Aviv, Israel, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Viewbix Inc. (Nasdaq: VBIX) (“Viewbix” or the “Company”), an advanced technologies company, today announced that it has received the requisite stockholder approval via written consent of the majority of its stockholders (the “Stockholder Consent”) for its previously announced acquisition of Quantum X Labs Ltd. (“Quantum”), a multi-disciplinary quantum technology hub focused on quantum algorithms, navigation, and atomic clocks.
The acquisition, which was entered into pursuant to the definitive share purchase agreement dated December 15, 2025 (the “Agreement Date”), involves Viewbix acquiring between
Quantum operates portfolio companies developing innovative solutions in quantum-based navigation (including GPS alternatives), next-generation atomic clocks for precision timing, quantum algorithms for sectors such as transportation, drug discovery, biomedicine, and security, as well as advanced quantum error correction technologies.
At closing, Viewbix will issue common stock and pre-funded warrants representing approximately
With stockholder approval secured via written consent, the transaction remains subject to satisfaction of remaining closing conditions, including final due diligence and regulatory approvals. The Company expects the acquisition to close in the coming weeks.
The Company intends to file a preliminary information statement on Schedule 14C (with the Securities and Exchange Commission on or about the date hereof. Pursuant to Delaware Law, the actions to be taken pursuant to the Stockholder Consent shall be effective on the 20th day after the definitive information statement on Schedule 14C is mailed or furnished to the Company’s stockholders.
About Viewbix Inc.
Viewbix, through certain of its subsidiaries Gix Media Ltd. and Metagramm Software Ltd., operates in the field of digital advertising. Gix Media develops a variety of technological software solutions, which perform automation, optimization and monetization of internet campaigns, for the purposes of acquiring and routing internet user traffic to its customers. Metagramm is a developer of grammatical error correction software. The company offers tools for writing and reviewing, grammar, spelling, punctuation and style features, as well as translation and multilingual dictionaries, using artificial intelligence and machine learning technology.
For more information about Viewbix, visit https://view-bix.com/
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995 and other Federal securities laws. Words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates” and similar expressions or variations of such words are intended to identify forward-looking statements. For example, the Company is using forward-looking statements when it discusses the timing and completion of the acquisition, the receipt of regulatory approvals, and the satisfaction of closing conditions related to the acquisition. Because such statements deal with future events and are based on Viewbix’s current expectations, they are subject to various risks and uncertainties, and actual results, performance or achievements could differ materially from those described in or implied by the statements in this press release.
The forward-looking statements contained or implied in this press release are subject to other risks and uncertainties, including those discussed in any filings with the SEC. Except as otherwise required by law, Viewbix undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release. Viewbix is not responsible for the contents of third-party websites.
Investor Relations Contacts:
Michal Efraty
Investor Relations
michal@efraty.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.